Please use this identifier to cite or link to this item:
|Title:||Recent advances of membrane-cloaked nanoplatforms for biomedical applications||Authors:||Ai, Xiangzhao
|Keywords:||Science::Chemistry||Issue Date:||2018||Source:||Ai, X., Hu, M., Wang, Z., Zhang, W., Li, J., Yang, H., . . . Xing, B. (2018). Recent advances of membrane-cloaked nanoplatforms for biomedical applications. Bioconjugate Chemistry, 29(4), 838-851. doi:10.1021/acs.bioconjchem.8b00103||Journal:||Bioconjugate Chemistry||Abstract:||In terms of the extremely small size and large specific surface area, nanomaterials often exhibit unusual physical and chemical properties, which have recently attracted considerable attention in bionanotechnology and nanomedicine. Currently, the extensive usage of nanotechnology in medicine holds great potential for precise diagnosis and effective therapeutics of various human diseases in clinical practice. However, a detailed understanding regarding how nanomedicine interacts with the intricate environment in complex living systems remains a pressing and challenging goal. Inspired by the diversified membrane structures and functions of natural prototypes, research activities on biomimetic and bioinspired membranes, especially for those cloaking nanosized platforms, have increased exponentially. By taking advantage of the flexible synthesis and multiple functionality of nanomaterials, a variety of unique nanostructures including inorganic nanocrystals and organic polymers have been widely devised to substantially integrate with intrinsic biomoieties such as lipids, glycans, and even cell and bacteria membrane components, which endow these abiotic nanomaterials with specific biological functionalities for the purpose of detailed investigation of the complicated interactions and activities of nanomedicine in living bodies, including their immune response activation, phagocytosis escape, and subsequent clearance from vascular system. In this review, we summarize the strategies established recently for the development of biomimetic membrane-cloaked nanoplatforms derived from inherent host cells (e.g., erythrocytes, leukocytes, platelets, and exosomes) and invasive pathogens (e.g., bacteria and viruses), mainly attributed to their versatile membrane properties in biological fluids. Meanwhile, the promising biomedical applications based on nanoplatforms inspired by diverse moieties, such as selective drug delivery in targeted sites and effective vaccine development for disease prevention, have also been outlined. Finally, the potential challenges and future prospects of the biomimetic membrane-cloaked nanoplatforms are also discussed.||URI:||https://hdl.handle.net/10356/140819||ISSN:||1043-1802||DOI:||10.1021/acs.bioconjchem.8b00103||Rights:||This document is the Accepted Manuscript version of a Published Work that appeared in final form in Bioconjugate Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.bioconjchem.8b00103||Fulltext Permission:||none||Fulltext Availability:||No Fulltext|
|Appears in Collections:||SPMS Journal Articles|
Updated on Jan 23, 2021
Updated on Jan 16, 2021
Updated on Jan 23, 2021
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.